Navigation Links
PeloBiotech to Distribute ReachBio’s Products in Germany, Austria and Switzerland
Date:10/28/2013

Seattle, WA (PRWEB) October 28, 2013

ReachBio LLC (Seattle, WA, USA) announced today that it has signed an agreement with PeloBiotech GmbH (Munich, Germany) giving PeloBiotech exclusive distribution rights to ReachBio’s full product line for the life science research market within Germany, Austria and Switzerland.

ReachBio provides research products and contract services for applications in basic life science research, drug research & development and toxicology. The company’s main product lines consist of ColonyGel™ methylcellulose-based media for hematopoietic colony-forming cell (CFC) assays and cryopreserved normal human primary cells isolated from blood, cord blood and bone marrow.

The extensive ColonyGel™ semi-solid media product line includes multiple formulations with different cytokine (growth factor) combinations optimized for the growth of the different progenitor cells in blood and bone marrow. In the cytokine-optimized, semi-solid environment provided by ColonyGel™, the different progenitors grow as morphologically distinct three-dimensional colonies that can be identified and scored microscopically. The ColonyGel™ line-up also includes formulations optimized for different species, including human, mouse, rat, dog and non-human primate. Applications of CFC assays using ColonyGel™ media include research into normal and abnormal hematological development, leukemia and cancer stem cells, cell therapy, stem cell biology, investigative toxicology, etc.

ReachBio’s line of normal primary human cells include highly purified cell types from blood such as the various subsets of T lymphocytes, B lymphocytes, natural killer cells and monocytes. It also includes “ReachBio Qualified” CD34+ and CD133+ stem cells/primitive progenitors purified from cord blood and bone marrow that have been pre-qualified in CFC assays. ReachBio also specializes in providing customized cell isolation services for customers with specific needs such as unique cell types, particular donor background or HLA type, repeat donor cell isolations, and/or customized vial sizes.

“ReachBio is extremely happy to have PeloBiotech representing our products in Germany, Austria and Switzerland,” said Rob Chaney, ReachBio’s General Manager and COO. “We have known Peter Frost, one of the founders of PeloBiotech, for many years and have the utmost respect for him and his knowledge of the life science research market within these research intensive countries. He has already been aiding ReachBio’s sales and business development efforts for our specialized cell biology contract research services in this same territory for the last few years with great results. So having him and PeloBiotech now representing our products as well is a great fit and makes perfect sense.”

Said Dr. Peter Frost, CEO of PeloBiotech, “We are delighted to now be distributing ReachBio’s ColonyGel™ and normal human cell products. The high quality of these products reflects the reputation for quality and value that ReachBio has built regarding both its contract research services and its products. ColonyGel™ provides researchers performing CFC assays a great alternative to the methylcellulose-based media provided by the leading competitor, which has become quite overpriced through many years of price increases. Additionally, we are happy that ReachBio is able to provide not only standard vials of high quality cryopreserved human cells but also flexible customized offerings. This is a great advantage to pharma companies that often have unique requirements for specific types of cells and a strong need for vial-to-vial and lot-to-lot reproducibility. This fits in very well with PeloBiotech’s goal to provide customized solutions to aid our customers’ research.”

About ReachBio LLC
ReachBio LLC is a life sciences organization based in Seattle, WA. It provides specialized contract research services and products to biopharmaceutical, biotechnology, and related organizations worldwide.

About PeloBiotech GmbH
PeloBiotech GmbH is based in Martinsried (near Munich), Germany and is a local distributor of high quality life science research tools and reagents with a focus on primary cell and stem cell biology, 3D cell culture and media development for human primary cells.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11272201.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Adimarket, Inc. Reaches Agreement with Equipmed to Promote and Distribute DermaPen Throughout Latin America and the Caribbean
2. Sigma Life Science and the Culture Collections of Public Health England Collaborate to Distribute Cells and Cellular Extracts
3. First Bedside DNA Test to be Distributed by Chirus in UK
4. Pinnaclife, Inc., Announces NDC, Inc., to Exclusively Distribute the New Animal Health Product Line!
5. ATCC Announces Agreement with Life Technologies Corporation to Sell and Distribute Green Fluorescent Protein (GFP)-based Materials
6. ZyGEM Teams With TATAA Biocenter To Distribute Its Innovative Nucleic acid Extraction Kits
7. Fleur de Lis Hydroponics Releases New Line of Hydroponic Products
8. The Future of Brazil Tobacco and Tobacco Products Packaging to 2017
9. Drug Discovery Using Natural Products - Optimization Studies of Inhibitors of Glucan Synthesis as Anti-Fungal Agents, New Life Science Webinar Hosted by Xtalks
10. BioConvergence® Presents Case Study on Temperature Controlled Pharmaceutical Products
11. Intrexon Establishes "Living Arts" Company, BioPop, to Create Consumer Products Inspired by Nature and Made Possible through Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... February 4, 2016 --> ... acceleration company is pleased to provide the following update on ... Over the last 3 months we have significantly increased ... agreements exceeding $1,000,000. As a result, we have positioned ourselves ... Inc. license agreement and expect that development to continue on ...
(Date:2/4/2016)... Feb. 4, 2016  Spherix Incorporated (Nasdaq: SPEX ... and monetization of intellectual property, today provided an update ... the Northern District of Texas ... Inter Partes Re-examination ("IPR") proceedings that ... The IPR was initiated on only certain claims of ...
(Date:2/4/2016)... ... February 04, 2016 , ... Franz Inc. , an ... technology has been recognized As “ Best in Semantic Web Technology - USA ... Corporate America, it’s our priority to showcase prominent professionals who are excelling in ...
(Date:2/4/2016)... ... ... Many of the engineers at FireflySci, Inc. have been manufacturing quartz and ... other cuvette manufacturers is their supercharged customer service and their extensive database of glass ... flow of inside information, they have recently revamped their manufacturing techniques to reduce lead ...
Breaking Biology Technology:
(Date:1/22/2016)... , Jan. 22, 2016 ... the addition of the "Global Biometrics ... to their offering. --> ... the "Global Biometrics Market in Retail ... --> Research and Markets ...
(Date:1/20/2016)... Jan. 20, 2016 A market that just ... benefit from the explosion in genomics knowledge. Learn all ... Research. A range of dynamic trends are pushing market ... personalized medicine - pharmacogenomics - pathogen evolution - next ... markets - greater understanding of the role of genetic ...
(Date:1/20/2016)... 20, 2016  Synaptics Incorporated (NASDAQ: SYNA ... today announced sampling of S1423, its newest ClearPad ... small screen applications including smartwatches, fitness trackers, and ... and rectangular shapes, as well as thick and ... moisture on screen, while wearing gloves, and supports ...
Breaking Biology News(10 mins):